dc.contributor.author
Muñoz-Torrero López-Ibarra, Diego
dc.contributor.author
Schopfer, Lawrence M.
dc.contributor.author
Lockridge, Oksana
dc.date.issued
2023-02-22T11:55:29Z
dc.date.issued
2023-02-22T11:55:29Z
dc.date.issued
2023-02-22T11:55:29Z
dc.identifier
https://hdl.handle.net/2445/193966
dc.description.abstract
Chronic low-dose exposure to organophosphorus (OP) toxicants is correlated with an increase in the risk of impaired cognition and neurodegenerative diseases. A mechanism to explain this relationship is needed. We suggest that the formation of organophosphate-induced high-molecular-weight protein aggregates that disrupt cell function may be the missing link. It has been demonstrated that such aggregation can be promoted by OP-labeled lysine. Alternatively, OP-labeled glutamate may be the initiator. To test this hypothesis, we treated MAP-rich tubulin Sus scrofa and human transglutaminase with chlorpyrifos oxon. Trypsin-digested proteins were subjected to liquid chromatography−tandem mass spectrometry followed by Protein Prospector searches to identify diethyl phosphate adducts and cross-linked peptides. We report the presence of diethyl phosphate adducts on the side chains of glutamate, lysine, and tyrosine, as well as cross-links between glutamate and lysine. Glutamate-lysine cross-linking could be initiated either by diethyl phosphate-activated glutamate or by diethyl phosphate-activated lysine to form stable isopeptide bonds between and within proteins. It was concluded that organophosphate-induced high-molecular-weight protein aggregates could promote brain dysfunction.
dc.format
application/pdf
dc.publisher
American Chemical Society
dc.relation
Reproducció del document publicat a: https://doi.org/10.1021/acs.chemrestox.2c00333
dc.relation
Chemical Research in Toxicology, 2023, vol. 36, num. 1, p. 112-121
dc.relation
https://doi.org/10.1021/acs.chemrestox.2c00333
dc.rights
cc by-nc-nd (c) Diego Muñoz-Torrero López-Ibarra, et al., 2023
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Malalties neurodegeneratives
dc.subject
Àcids nucleics
dc.subject
Neurodegenerative Diseases
dc.title
Chlorpyrifos oxon activates glutamate and lysine for protein cross-linking
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion